vimarsana.com

Profund Advisors LLC grew its stake in Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report) by 51.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 91,038 shares of the company’s stock after acquiring an additional 31,029 shares during the quarter. Profund […]

Related Keywords

China ,Annm Hanly ,Georgea Scangos , ,China Universal Asset Management Co ,Profund Advisors ,Cm Bidwell Associates Ltd ,Nasdaq ,Exchange Commission ,Fifth Third Bancorp ,Needham Company ,Securities Exchange Commission ,Jpmorgan Chase Co ,Vir Biotechnology Inc ,Third Bancorp ,Vir Biotechnology ,Free Report ,Universal Asset Management ,Financial Advisors ,Quantbot Technologies ,Get Free Report ,Director George ,Visit Holdingschannel ,Vir Biotechnology Daily ,Nasdaq Vir ,Ivir ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.